StockUnited StatesNYSE

PFE

Pfizer Inc.

Healthcare · Drug Manufacturers - General

30.03USD

-0.3900 (-1.28%)

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out

Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
A take fades: it counts half as much after 7 days and drops out after 30.
Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
Your own take is private: only the totals are shown, and never who said what.

Description Historical Financials Relative Value Research News Community Room OptionsPrice Chart ↗Fundamental Chart ↗

Valuation

P/E (TTM)

39.51x

P/E (Forward)

10.41x

EV/EBITDA

8.79x

EV/Revenue

3.50x

P/S (TTM)

2.69x

P/B

2.01x

FCF Yield

6.42%

Dividend Yield

5.73%

Gross Margin

73.18%

Operating Margin

27.88%

Net Margin

6.80%

Peer Comparison — Drug Manufacturers - General

Company	Mkt Cap	P/E	EV/EBITDA	FCF Yield	Rev Growth	Div Yield
PFEPfizer Inc.	$171.16B	39.51x	8.79x	6.42%	2.60%	5.73%
LLYEli Lilly and Company	$1.14T	42.75x	28.32x	0.97%	47.70%	0.54%

Subject metrics from SEC filings where available; peer metrics from cached market data.

Computing valuation metrics…